Ursula Kahl1, Yuanyuan Yu1, Axel Nierhaus2, Daniel Frings2, Barbara Sensen2, Anne Daubmann3, Stefan Kluge2, Marlene Fischer4,5. 1. Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. 2. Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 3. Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4. Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. mar.fischer@uke.de. 5. Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. mar.fischer@uke.de.
Abstract
BACKGROUND: Early hypercapnia is common in patients with acute respiratory distress syndrome (ARDS) and is associated with increased mortality. Fluctuations of carbon dioxide have been associated with adverse neurological outcome in patients with severe respiratory failure requiring extracorporeal organ support. The aim of this study was to investigate whether early hypercapnia is associated with impaired cerebrovascular autoregulation during the acute phase of ARDS. METHODS: Between December 2018 and November 2019, patients who fulfilled the Berlin criteria for ARDS, were enrolled. Patients with a history of central nervous system disorders, cerebrovascular disease, chronic hypercapnia, or a life expectancy of less than 24 h were excluded from study participation. During the acute phase of ARDS, cerebrovascular autoregulation was measured over two time periods for at least 60 min. Based on the values of mean arterial blood pressure and near-infrared spectroscopy, a cerebral autoregulation index (COx) was calculated. The time with impaired cerebral autoregulation was calculated for each measurement and was compared between patients with and without early hypercapnia [defined as an arterial partial pressure of carbon dioxide (PaCO2) ≥ 50 mmHg with a corresponding arterial pH < 7.35 within the first 24 h of ARDS diagnosis]. RESULTS: Of 66 patients included, 117 monitoring episodes were available. The mean age of the study population was 58.5 ± 16 years. 10 patients (15.2%) had mild, 28 (42.4%) moderate, and 28 (42.4%) severe ARDS. Nineteen patients (28.8%) required extracorporeal membrane oxygenation. Early hypercapnia was present in 39 patients (59.1%). Multivariable analysis did not show a significant association between early hypercapnia and impaired cerebrovascular autoregulation (B = 0.023 [95% CI - 0.054; 0.100], p = 0.556). Hypocapnia during the monitoring period was significantly associated with impaired cerebrovascular autoregulation [B = 0.155 (95% CI 0.014; 0.296), p = 0.032]. CONCLUSION: Our results suggest that moderate permissive hypercapnia during the acute phase of ARDS has no adverse effect on cerebrovascular autoregulation and may be tolerated to a certain extent to achieve low tidal volumes. In contrast, episodes of hypocapnia may compromise cerebral blood flow regulation. Trial registration ClinicalTrials.gov; registration number: NCT03949738; date of registration: May 14, 2019.
BACKGROUND: Early hypercapnia is common in patients with acute respiratory distress syndrome (ARDS) and is associated with increased mortality. Fluctuations of carbon dioxide have been associated with adverse neurological outcome in patients with severe respiratory failure requiring extracorporeal organ support. The aim of this study was to investigate whether early hypercapnia is associated with impaired cerebrovascular autoregulation during the acute phase of ARDS. METHODS: Between December 2018 and November 2019, patients who fulfilled the Berlin criteria for ARDS, were enrolled. Patients with a history of central nervous system disorders, cerebrovascular disease, chronic hypercapnia, or a life expectancy of less than 24 h were excluded from study participation. During the acute phase of ARDS, cerebrovascular autoregulation was measured over two time periods for at least 60 min. Based on the values of mean arterial blood pressure and near-infrared spectroscopy, a cerebral autoregulation index (COx) was calculated. The time with impaired cerebral autoregulation was calculated for each measurement and was compared between patients with and without early hypercapnia [defined as an arterial partial pressure of carbon dioxide (PaCO2) ≥ 50 mmHg with a corresponding arterial pH < 7.35 within the first 24 h of ARDS diagnosis]. RESULTS: Of 66 patients included, 117 monitoring episodes were available. The mean age of the study population was 58.5 ± 16 years. 10 patients (15.2%) had mild, 28 (42.4%) moderate, and 28 (42.4%) severe ARDS. Nineteen patients (28.8%) required extracorporeal membrane oxygenation. Early hypercapnia was present in 39 patients (59.1%). Multivariable analysis did not show a significant association between early hypercapnia and impaired cerebrovascular autoregulation (B = 0.023 [95% CI - 0.054; 0.100], p = 0.556). Hypocapnia during the monitoring period was significantly associated with impaired cerebrovascular autoregulation [B = 0.155 (95% CI 0.014; 0.296), p = 0.032]. CONCLUSION: Our results suggest that moderate permissive hypercapnia during the acute phase of ARDS has no adverse effect on cerebrovascular autoregulation and may be tolerated to a certain extent to achieve low tidal volumes. In contrast, episodes of hypocapnia may compromise cerebral blood flow regulation. Trial registration ClinicalTrials.gov; registration number: NCT03949738; date of registration: May 14, 2019.
Authors: Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho Journal: N Engl J Med Date: 1998-02-05 Impact factor: 91.245
Authors: Yiorgos Alexandros Cavayas; Laveena Munshi; Lorenzo Del Sorbo; Eddy Fan Journal: Am J Respir Crit Care Med Date: 2020-06-15 Impact factor: 21.405
Authors: Nicolas Nin; Alfonso Muriel; Oscar Peñuelas; Laurent Brochard; José Angel Lorente; Niall D Ferguson; Konstantinos Raymondos; Fernando Ríos; Damian A Violi; Arnaud W Thille; Marco González; Asisclo J Villagomez; Javier Hurtado; Andrew R Davies; Bin Du; Salvatore M Maggiore; Luis Soto; Gabriel D'Empaire; Dimitrios Matamis; Fekri Abroug; Rui P Moreno; Marco Antonio Soares; Yaseen Arabi; Freddy Sandi; Manuel Jibaja; Pravin Amin; Younsuck Koh; Michael A Kuiper; Hans-Henrik Bülow; Amine Ali Zeggwagh; Antonio Anzueto; Jacob I Sznajder; Andres Esteban Journal: Intensive Care Med Date: 2017-01-20 Impact factor: 17.440
Authors: Clinton H Doerr; Ognjen Gajic; Jorge C Berrios; Sean Caples; Matthew Abdel; James F Lymp; Rolf D Hubmayr Journal: Am J Respir Crit Care Med Date: 2005-02-01 Impact factor: 21.405
Authors: Luis Morales-Quinteros; Marta Camprubí-Rimblas; Josep Bringué; Lieuwe D Bos; Marcus J Schultz; Antonio Artigas Journal: Intensive Care Med Exp Date: 2019-07-25
Authors: Arturo Briva; István Vadász; Emilia Lecuona; Lynn C Welch; Jiwang Chen; Laura A Dada; Humberto E Trejo; Vidas Dumasius; Zaher S Azzam; Pavlos M Myrianthefs; Daniel Batlle; Yosef Gruenbaum; Jacob I Sznajder Journal: PLoS One Date: 2007-11-28 Impact factor: 3.240